Paul Walker
Investing Profile
Sweet spot: $25M
Range: $2M–$50M
Fund: $6.2B
Sector and stage focus
- Series B: BioTech, Pharmaceuticals, Health & Hospital Services, Health IT
- Series A: BioTech, Health IT, Pharmaceuticals, Health & Hospital Services
- general: San Francisco Bay Area
Recent investments by Paul Walker
Paul Walker has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Allakos | Post Ipo Equity | Sep 2022 | $150M |
| Xenon Pharmaceuticals | Post Ipo Equity | Sep 2018 | $63M |
| Regulus Therapeutics | Post Ipo Equity | Nov 2021 | $35M |
| Phathom Pharmaceuticals | Post Ipo Equity | May 2023 | $150M |
| Geron | Post Ipo Equity | May 2020 | $150M |
| Savara Pharmaceuticals | Post Ipo Equity | Mar 2021 | $130M |
| CTI BioPharma | Post Ipo Equity | Feb 2018 | $69M |
Frequent co-investors
Paul Walker has co-invested with: Blake Wu.
Is Paul Walker a fit for your round?
Upload your pitch deck and see whether Paul Walker appears in your top 20 matches.
Find investors for your deck